Delayed branching of endothelial capillary-like cords in glycated collagen I is mediated by early induction of PAI-1

American Journal of Physiology - Renal Physiology

Volumn 281, Issue 1 50-1, 2001, Pages

  Chen, Jun ^a   Brodsky, Sergey ^a   Li, Hong ^a   Hampel, Dierk J ^a   Miyata, Toshio ^b   Weinstein, Talia ^c   Gafter, Uzi ^c   Norman, Jill T ^d   Fine, Leon G ^d   Goligorsky, Michael S ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; CDNA differential display; Diabetic nephropathy; Extracellular matrix; Glycation end products; Plasminogen activator inhibitor 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 1; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PROLIFERATION; CELL GROWTH; COLLAGEN METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; GLYCATION; HUMAN; HUMAN CELL; KIDNEY INTERSTITIUM; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; UMBILICAL VEIN; WESTERN BLOTTING; WOUND HEALING;

EID: 15444378956     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.281.1.f71     Document Type: Article

References (57)

1. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy
2. Non-enzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane
3. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury
4. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
5. Glycated proteins modulate tissue-plasminogen activator-catalized plasminogen activation
6. The obliteration of the postglomerular capillaries and its influence on the function of both glomeruli and tubules
7. Glycosylation products as toxic mediators of diabetic complications
8. Nonenzymatic glycosylation and the pathogenesis of diabetic complications
9. Physiological consequences of loss of plasminogen activator gene function in mice
10. Plasminogen activator inhibitor-1 gene deficient mice
11. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
12. Serial analysis of gene expression to assess the endothelial response to an atherogenic stimulus
13. Age-dependent accumulation of Ne-(carboxymethyl)lysine and Ne-(carboxymethyl) hydroxylysine in human skin collagen
14. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
15. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells
16. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats
17. Altered proliferation of retinal microvascular cells on glyeated matrix
18. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy
19. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
20. Renal interstitial expansion in insulin-dependent diabetes mellitus
21. Pexicrine effects of basement membrane components on paracrine signaling by renal tubulat cells
22. The intrarenal arterial pattern in the normal and diseased human kidney
23. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose
24. Immunochemical detection of advanced glycosylation end products in vivo
25. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?
26. Accelerated age-related browning of human collagen in diabetes mellitus
27. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence
28. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices
29. Suppression subtraction hybridization identifies high-glucose levels as a stimulus for expression of connective tissue growth factor and other genes I human mesangial cells
30. Histotypic angiogenesis in vitro: Light microscopic, ultrastructural and radioautographic studies
31. The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model
32. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells
33. A rapid, and convenient assay for counting cells in microwell plates: Application for assessment of growth factors
34. Hypoxia stimulates proximal tubular cell matrix production via a TGF-β1-independent mechanism
35. Impaired wound healing in mice with a disrupted plasminogen gene
36. Transforming growth factor-β selectively inhibits branching morphogenesis but not tubulogenesis
37. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging
38. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
39. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice
40. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin
41. Number of interstitial capillary cross-sections assessed by monoclonal antibodies: Relation to interstitial damage
42. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae
43. The serpin PAI-1 inhibits cell migration by blocking integrin αVβ3 binding to vitronectin
44. Relationship between fasting plasma glucose, atrherosclrosis risk factors and carotid intima:mdia thickness in non-diabetic individuals
45. Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured HUVEC
46. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells
47. The plasminogen activator/plasmin system
48. Elevated PAI levels in cyclosporin-treated renal allograft recipients
49. Recent progress in advanced glycation end products and diabetic complications
50. Pathogenic effects of advanced glycosylation: Biochemical, biologic and clinical implications for diabetes and aging
51. Exogenous advanced glycosylation endproducts induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications
52. Regulation of integrin function by the urokinase receptor
53. Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system
54. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells
55. AGE products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor
56. Requirement of receptor-bound urokinase-type plasminogen activator for integrin αVβ3-directed cell migration
57. Significance of tubulointerstitial changes in diabetic renal disease